80
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Distinctive Activated Cellular Subsets in Colon from Patients with Crohn's Disease and Ulcerative Colitis

Pages 743-748 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jitin Makker & Daniel W. Hommes. (2016) Etrolizumab for ulcerative colitis: the new kid on the block?. Expert Opinion on Biological Therapy 16:4, pages 567-572.
Read now
Ian Craig Lawrance. (2012) Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease. Expert Opinion on Investigational Drugs 21:7, pages 975-984.
Read now
Yehuda E. Deutsch, Tamar Tadmor, Eckhard R. Podack & Joseph D. Rosenblatt. (2011) CD30: an important new target in hematologic malignancies. Leukemia & Lymphoma 52:9, pages 1641-1654.
Read now
P. D. Thomas, A. Forbes, R. J. Nicholls, P. J. Ciclitira. (2001) Altered Expression of the Lymphocyte Activation Markers CD30 and CD27 in Patients with Pouchitis. Scandinavian Journal of Gastroenterology 36:3, pages 258-264.
Read now

Articles from other publishers (16)

Carolijn Smids, Carmen S. Horjus Talabur Horje, Femke van Wijk & Ellen G. van Lochem. (2016) The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis, pages jjw163.
Crossref
Shinichi Somada, Hiromi Muta, Kazuhiko Nakamura, Xun Sun, Kuniomi Honda, Eikichi Ihara, Hirotada Akiho, Ryoichi Takayanagi, Yasunobu Yoshikai, Eckhard R. Podack & Kenzaburo Tani. (2012) CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease. Digestive Diseases and Sciences 57:8, pages 2031-2037.
Crossref
EG Stefanich, DM Danilenko, H Wang, S O'Byrne, R Erickson, T Gelzleichter, H Hiraragi, H Chiu, S Ivelja, S Jeet, S Gadkari, O Hwang, F Fuh, C Looney, K Howell, V Albert, M Balazs, C Refino, S Fong, S Iyer & M Williams. (2011) A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes. British Journal of Pharmacology 162:8, pages 1855-1870.
Crossref
S.D. McLaughlinS.K. Clark, P.P. Tekkis, R.J. Nicholls & P.J. Ciclitira. (2010) The bacterial pathogenesis and treatment of pouchitis. Therapeutic Advances in Gastroenterology 3:6, pages 335-348.
Crossref
Lianne K.P.M. Brakenhoff, Désirée M. van der Heijde, Daniel W. Hommes, Tom W.J. Huizinga & Herma H. Fidder. (2010) The joint–gut axis in inflammatory bowel diseases. Journal of Crohn's and Colitis 4:3, pages 257-268.
Crossref
Boulos Haraoui & Marilyn Krelenbaum. (2009) Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action. Seminars in Arthritis and Rheumatism 39:3, pages 176-181.
Crossref
Tatiana Sofía Rodríguez-Reyna, Cynthia Martínez-Reyes & Jesús Kazúo Yamamoto-Furusho. (2009) Rheumatic manifestations of inflammatory bowel disease. World Journal of Gastroenterology 15:44, pages 5517.
Crossref
Ouafae Karimi & Amado Salvador Peña. (2008) Indications and Challenges of Probiotics, Prebiotics, and Synbiotics in the Management of Arthralgias and Spondyloarthropathies in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 42:Supplement 3, pages S136-S141.
Crossref
Maria Apostolaki, Menelaos Manoloukos, Manolis Roulis, Marc–André Wurbel, Werner Müller, Konstantinos A. Papadakis, Dimitris L. Kontoyiannis, Bernard Malissen & George Kollias. (2008) Role of β7 Integrin and the Chemokine/Chemokine Receptor Pair CCL25/CCR9 in Modeled TNF-Dependent Crohn's Disease. Gastroenterology 134:7, pages 2025-2035.
Crossref
Martin Rudwaleit & Dominique Baeten. (2006) Ankylosing spondylitis and bowel disease. Best Practice & Research Clinical Rheumatology 20:3, pages 451-471.
Crossref
Filip De Keyser, Dominique Baeten, Filip Van den Bosch, Elli Kruithof, Herman Mielants & Eric M Veys. (2003) Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. Rheumatic Disease Clinics of North America 29:3, pages 463-479.
Crossref
Filip De Keyser, Dominique Baeten, Filip Van den Bosch, Martine De Vos, Claude Cuvelier, Herman Mielants & Eric Veys. (2002) Gut inflammation and spondyloarthropathies. Current Rheumatology Reports 4:6, pages 525-532.
Crossref
Dominique Baeten, Filip De Keyser, Herman Mielants & Eric M Veys. (2002) Ankylosing spondylitis and bowel disease. Best Practice & Research Clinical Rheumatology 16:4, pages 537-549.
Crossref
Charles N. Bernstein, Michael Sargent & Edward Rector. (2002) Alteration in Expression of β2 Integrins on Lamina Propria Lymphocytes in Ulcerative Colitis and Crohn's Disease. Clinical Immunology 104:1, pages 67-72.
Crossref
Seiji Arihiro, Haruo Ohtani, Manabu Suzuki, Masahiro Murata, Chieko Ejima, Motoji Oki, Yoshitaka Kinouchi, Kouhei Fukushima, Iwao Sasaki, Shiro Nakamura, Takayuki Matsumoto, Akira Torii, Gotaro Toda & Hiroshi Nagura. (2002) Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease. Pathology International 52:5-6, pages 367-374.
Crossref
Alvina Chu, Kenneth Hong, Ellen L. Berg & Rolf O. Ehrhardt. (1999) Tissue Specificity of E- and P-Selectin Ligands in Th1-Mediated Chronic Inflammation. The Journal of Immunology 163:9, pages 5086-5093.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.